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Abstract We investigated the prevalence of migraine
(MIG), tension-type headache (TTH), and chronic headache
in a population-based sample in Germany. A total of 18,000
subjects aged between 18 and 65 years were screened from
2003 until 2005 using a validated questionnaire. Overall
9,944 participants (55.2%) responded (mean age 43 ±
13.1 years, 52.7% women). Headache frequency\15 days/
month was reported by 5,350 (55.5%) subjects of whom
1,601 (16.6%, [95% conﬁdence interval (95% CI): 15.9–
17.4]) reported episodic MIG, 1,202 (12.5%, 95% CI
11.8–13.1) episodic TTH, and 1,150 (11.9%, [11.3–12.6])
episodic MIG ? episodic TTH, 1,396 (14.5%, [13.8–15.2])
unclassiﬁable headache. In women, episodic MIG peaked
between 36 and 40 years, episodic MIG ? TTH between
18 and 35 years and episodic TTH between 56 and
66 years. In men, episodic MIG was predominant between
36 and 45 years, episodic MIG ? TTH between 26 and
35 years and episodic TTH showed comparable frequency
between 36 and 66 years. Headache C15 days/month was
reported by 2.6% (n = 255, [95% CI 2.3–3]). Chronic MIG
was reported by 1.1% (n = 108, [0.91–1.33]), chronic TTH
(n = 50, [95% CI 0.4–0.7]), chronic MIG ? TTH 0.8%
(n = 74, 95% CI 0.6–0.9) and unclassiﬁable headache 0.2%
(n = 23, [95% CI 0.1–0.3]). Chronic headache was more
frequent in women compared to men with the highest
prevalence between 46 and 65 years. It is of note that the
number of subjects with chronic headache is small in all age
groups. The results of our large, population-based study
provide reliable, age- and sex-speciﬁc estimates of the
prevalence of primary headache disorders in Germany. The
prevalence with respect to episodic and chronic primary
headache disorders in Germany is comparable to other
European countries and the USA.
Keywords Migraine  Tension-type headache 
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Introduction
The two most common primary headache disorders,
migraine (MIG) andtension-type headache(TTH),affect up
to 80% of the general population worldwide [1]. Both dis-
orders are classiﬁed by the International Headache Society
(IHS) into two different categories depending on headache
frequency: episodic (\15 headache days per month) and
chronic (C15 headache days per month) [2]. Chronic daily
headache [including both, chronic migraine (cMIG) and
chronic TTH (cTTH)] is quite common and affects
approximately 3–4% of the general population [3–5]. In
particular, cMIG is associated with a signiﬁcant burden of
illness for individuals, their families and the society [6, 7].
However, comprehensive data of the prevalence in the
general population with respect to age and sex are rare. The
German Headache Consortium Study (GHC) is an ongoing
population-based, longitudinal cohort study designed to
investigate the prevalence and incidence of primary
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Here, we present detailed baseline data on the prevalence of
MIG, TTH and chronic headache by age and sex.
Methods
Study design and study population
Baseline data of the GHC were assessed between 2003 and
2005. The study was approved by the ethics committee of
the University of Duisburg-Essen, Germany. Informed
written consent was obtained via postal mail from all
subjects. Subjects were randomly selected from statutory
lists of residence drawn from three regions in Germany: the
city of Essen, a large town (585,481 residents) in the region
of North Rhine-Westphalia in the western part of Germany;
the city of Muenster, a medium-sized town (272,890 resi-
dents), also in the western part of Germany; and Sigmar-
ingen, a rural area, consisting of a small town with 16,501
inhabitants and 20 surrounding villages in southern
Germany. Inclusion criteria were: (i) age between 18 and
65 years, and (ii) German citizenship, to ensure proper
knowledge of the German language in order to properly ﬁll
out the questionnaire.
Figure 1 illustrates the ﬂow chart of the screening pro-
cedure. Eighteen thousand randomly selected subjects
received a questionnaire via postal mail (Fig. 1). Subjects
who did not respond (44.8%) were called for at least eight
times for an interview by telephone. Interviews were per-
formed by trained medical students using the same ques-
tionnaire. Main reasons for non-response by phone were
that subjects could not be reached (32.9%) or refused the
interview (8.7%; Fig. 2). Overall, we obtained information
per mailed questionnaire or telephone interview from
n = 9,944 (55.2%) participants.
Questionnaire
The questionnaire was constructed based on the criteria of
the IHS [8] and validated prior to the survey in 278
patients. The results of the validation were reported else-
where [4, 9]. First, the participants were asked if they
experienced any kind of headache in the last year. The
questionnaire was designed to collect demographic data,
and information regarding MIG, TTH and trigeminal
Fig. 1 Screening procedure.
Eighteen thousand randomly
selected subjects received a
questionnaire via postal mail.
Subjects who did not respond
were called for at least eight
times for an interview by
telephone. Main reasons for
non-response by phone were
that subjects were not available
or refused the interview.
Overall, we obtained
information per mailed
questionnaire or telephone
interview from n = 9,944
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123autonomic cephalalgias in the last 3 months. Notably, the
questionnaire allowed for the diagnosis of each headache
type. For example, in a person with more than one head-
ache type, one headache type might be classiﬁed as MIG
and another as TTH. The questionnaire asked a series of
questions that allowed for the diagnosis of migraine and/or
TTH according to the deﬁnition of the revised version of
the international classiﬁcation of headache disorders
(ICHD-II) and the assessment of headache attack frequency
per month in migraine and TTH.
The questionnaire did not allow for the diagnosis of each
headache attack; this type of data is best ascertained
through a daily headache diary.
Diagnostic criteria
Deﬁnitive migraine was diagnosed if all IHS criteria were
met, probable MIG if all but one IHS criteria were fulﬁlled,
but the participant did not fulﬁll the IHS criteria for TTH.
Deﬁnitive TTH was deﬁned if all IHS criteria were met,
probable TTH if all but one IHS criteria for TTH was met,
but the participant did not fulﬁll the IHS criteria for MIG.
Chronic daily headache was deﬁned as headache present on
C15 days/month and not meeting criteria for trigeminal
autonomic cephalalgias (TACs). Overlap between MIG and
TTH as well as either MIG or TTH and headache on
C15 days/month was possible because the latter included
chronic MIG and chronic TTH. Episodic primary headache
disorders,deﬁniteMIGanddeﬁniteTTHaswellasprobable
MIG and probable TTH were summarized as episodic All-
MIG (epAll-MIG) and episodic All-TTH (epAll-TTH) [10].
Statistical analysis
The aim of the current manuscript was to provide detailed
information on the prevalence of primary headaches
stratiﬁed by age and gender. Therefore, all results are
provided as percentages in which number of cases is
divided by the number of responders who duly completed
the questionnaire. Categorical variables were described as
percentages with their 95% conﬁdence intervals (95% CI).
All analyses were carried out using SPSS, version 14.0
(SPSS Inc., Chicago, IL, USA).
Results
Overall 9,944 (55.2%) individuals responded (Fig. 2). Of
these 4,640 (25.8%) answered via postal mail, and 5,304
(29.5%) by telephone. 8,056 (44.8%) were non-responder, of
whom 1,565 (8.7%) refused the interview, 5,924 (32.9%)
couldnotbereached,381(2.1%)movedawayand186(1.0%)
were debilitated or deceased. Non-responder tended to be
younger (39.8 ± 12.6 resp. 43.0 ± 13.1 years) and were
slightly more often men (men 53.3%, women 46.7%). Infor-
mation on headache type was missing in 31 (0.3%) ques-
tionnaires (Fig. 3). These subjects only answered whether
theyexperiencedanykindofheadachelastyear.In278(2.8%)
cases, data about headache frequency were missing (Fig. 3).
In 9,912 cases, data about headache type were complete.
The questionnaire was completed by 9,635 respondents.
All primary headache disorders (n = 9,912)
Table 1 shows the prevalence of headache disorders sepa-
rated into episodic and chronic headache conditions strati-
ﬁed by sex and age groups. The prevalence was as follows:
All-MIG 17.9% (n = 1,774; [95% CI 17.1–18.6]), All-
TTH 13.3% (n = 1,317; [95% CI 12.6–13.9]), All-MIG ?
TTH12.8%(n = 1,272;[95%CI12.2–13.5]),unclassiﬁable
headache 15.3% (n = 1,520; [95% CI 14.6–16.0])
(Table 1).Inwomen,All-MIG(23.9%;[95%CI22.8–25.1])
and unclassiﬁable headache were most frequent (15.7%;
[95% CI 14.7–16.7]). All-MIG ? TTH and All-TTH were
quite similar (Table 1). The prevalence among men was as
follows: All-MIG 11.1% (n = 522; [95% CI 10.2–12.0]),
All-TTH12.0%(n = 561;[95%CI11.0–12.9]),All-MIG ?
TTH 10.6% (n = 498; [95% CI 9.7–11.5]), unclassiﬁable
headache14.9%(n = 701;[95%CI13.9–15.9]).Itisofnote
thatparticipantswithmigrainewereidentiﬁedtosuffermore
from deﬁnite migraine than probable migraine (3.1-fold),
whereasintension-typeheadacheandMIG ? TTHsubjects
tendtosuffermoreprobableTTHandprobableMIG ? TTH
(2.7- and 1.5-fold).
Episodic headache (N = 9,635)
Figure 3 depicts the overall prevalence of headache in
9,635 participants followed by the distribution of headache
Fig. 2 Responder versus non-responder. Overall 9,944 (55.2%)
individuals responded of whom 4,640 (25.8%) answered via postal
mail, and 5,304 (29.5%) by telephone. 8,056 (44.8%) were non-
responder, of whom 1,565 (8.7%) refused the interview, 5,924
(32.9%) could not be reached, 381 (2.1%) moved away and 186
(1.0%) were debilitated or deceased
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123type, out of which 55.5% reported headache that occurred
on less than 15 days per month. Table 2 shows the prev-
alence of episodic headache types with regards to sex and
age group. Of those suffering from headache, episodic All-
MIG was the most common reported headache type with
29.9% (n = 1,601; [95% CI 28.7–31.2]), followed by
unclassiﬁable episodic headache 26.1% (n = 1,396; [95%
CI 24.9–27.3]), epAll-TTH 22.5% (n = 1,202; [95% CI
21.4–23.6]), and epAll-MIG ? TTH 21.5% (n = 1,150;
[95% CI 20.4–22.6]).
Among women epAll-MIG was the most frequent
(34.4%, 32.8–36.1), whereas all other headache types were
almost equally distributed. In men, unclassiﬁable headache
was 30.6% (n = 629; [95% CI 28.6–32.6]), followed by
epAll-TTH 24.6% (n = 505; [95% CI 22.7–26.5]), epAll-
MIG 22.7% (n = 466; [95% CI 20.9–24.5]) and epAll-
MIG ? TTH 22.1% (n = 453; [95% CI 20.3–23.9]).
Compared to men, women reported 2.4-fold increase of
epAll-MIG, 1.4 of epAll-TTH, and 1.5 of epAll-MIG ?
TTH.
In relation to age, Table 2 shows that in women epAll-
MIG peaks between 36 and 45 years and epAll-TTH and
epAll-MIG ? TTH between 18 and 35 years. In men,
epAll-MIG peaks between 36 and 45 years, epAll-TTH
show similar frequency in the age groups between 36 and
66 years and epAll-MIG ? TTH show two peaks in the
age groups 26 and 35 years and 46 and 55 years (Table 2).
Chronic headache
We identiﬁed 255 participants that reported headache on at
least 15 days/month resulting in a prevalence of 2.6%
(95% CI 2.3–3) (Table 3). The prevalence was as follows:
chronic MIG 42.4% (n = 108; [95% CI 36.3–48.4]),
chronic MIG ? TTH 29% (n = 74; [95% CI 23.5–34.6]),
chronic TTH 19.6% (n = 50; [95% CI 14.7–24.5]) and
Fig. 3 Prevalence of episodic
and chronic primary headache
disorders. In total, 9,944
participants responded of whom
in 31 cases (0.3%) information
on headache type was missing.
In 278 (2.8%) cases, data about
headache frequency were
missing. The questionnaire was
duly completed by 9,635
respondents. Episodic headache
was reported by 55.5%, chronic
headache by 2.6% and no
headache by 41.8% of the
participants
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123unclassiﬁable headache 9% (n = 23; [95% CI 5.5–12.5]).
Women were more frequently affected than men (65.1 vs.
34.9%). Apparently chronic headache in women tends to
become a bigger problem with increasing age (Table 3). In
particular, chronic MIG and chronic MIG ? TTH in
women peak between 36 and 55 years, whereas chronic
TTH peaks in the age group 56 and 66 years. In men
chronic MIG peaks between 26 and 35 years, chronic
MIG ? TTH between 18 and 25 years and chronic TTH
between 46 and 55 years.
Discussion
Population-based surveys assessing the prevalence of pri-
mary headache disorders in Germany are rare. The aim of
our present work was to provide prevalence data of primary
headache disorders including episodic and chronic head-
ache forms in relation to sex and age in the general pop-
ulation in Germany. About 55% of the participants reported
any kind of headache within the last 12 months.
As far as migraine is concerned, our results are com-
parable to previous studies from other European countries
and the USA [11–16]. The prevalence of migraine in
Sweden was 13.2, 16.7% among women and 9.5% among
men [11], in England 18.3% among women and 7.6%
among men [15] compared to the 13.4% of migraine
prevalence in our study, 19.1% among women and 7.1%
among men. The estimated prevalence of deﬁnite MIG and
probable MIG in France and Austria was similar: 11.2% for
deﬁnite MIG and 10.1% for probable MIG in France [13],
10.2% for deﬁnite MIG and 8.5% for probable MIG in
Austria [12] compared to 13.4% deﬁnite MIG and 4.4%
probable MIG in the present study. In the USA, the prev-
alence of MIG is about 17% in women and 6% in men [14,
16] which is comparable to our data as well (19.1% in
women and 7.1% in men).
Previous data on the prevalence of TTH are more het-
erogeneous. In Germany, the lifetime prevalence of TTH
was reported to be 38.5% [6]. The 1-year prevalence in
Croatia was 20.7% [17]. In Denmark, the 1-year prevalence
of TTH in men was found to be 63 and 86% in women
[18]. Several reasons may lead to this wide variation of
estimated prevalence in TTH. For example, questionnaires
may differ in their sensitivity to identify cases where
respondents consider their symptoms trivial. The estimated
1-year prevalence of episodic TTH in our survey is com-
parable to estimates in Croatia [17] but is lower than pre-
vious estimates in Germany [6], in Georgia [10] and in
Denmark [18].
We found 1,392 subjects with a headache frequency
\15 days/month but with missing data to allow for further
headache classiﬁcation. Trigeminal autonomic cephalalgias
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123(TAC) and other primary headache disorders are unlikely
to be detected in a population-based setting since the
prevalence of these headache syndromes is rather low.
Patients with TACs might be easily misclassiﬁed as either
MIG or TTH leading to diverse results in either direction
dependent on the design and focus of the respective
questionnaire. As migraine is diagnosed essentially on the
presence of speciﬁc features, and TTH by the absence of
those same features, we think that these cases were most
probably classiﬁed as TTH rather than migraine by our
questionnaire.
In our population, the overall 1-year prevalence of
chronic headache was 2.6%. These results are in line with
studies from Western Europe and the USA [19–21]. In
Western Europe, chronic headache was reported to be 4.7%
in participants aged over 14 years [19] out of which
Table 2 Episodic primary
headache disorder
CI conﬁdence interval,
epAllMIG episodic all migraine,
epAllTTH episodic all tension-
type headache, epUnclassiﬁable
episodic unclassiﬁable,
epAllMIG ? TTH episodic all
migraine ? tension-type
headache, epHeadache episodic
headache
epHeadache
age group
N epAllMIG
n (%)
[95% CI]
epAllMIG ? TTH
n (%)
[95% CI]
epAllTTH
n (%)
[95% CI]
epUnclassiﬁable
n (%)
[95% CI]
All
18–25 854 221 (25.9)
[22.9–28.8]
194 (22.7)
[19.9–25.5]
177 (20.7)
[18–23.4]
262 (30.7)
[27.6–33.8]
26–35 1,116 328 (29.4)
[26.7–32.1]
262 (23.5)
[21–26]
218 (19.5)
[17.2–21.9]
308 (27.6)
[25–30.2]
36–45 1,482 498 (33.6)
[31.2–36]
318 (21.5)
[19.4–23.6]
344 (23.2)
[21.1–25.4]
322 (21.7)
[19.6–23.8]
46–55 1,190 367 (30.8)
[28.2–33.5]
249 (20.9)
[18.6–23.2]
279 (23.4)
[21–25.9]
295 (24.8)
[22.3–27.2]
56–66 707 187 (26.4)
[23.2–29.7]
127 (18)
[15.1–20.8]
184 (26)
[22.8–29.3]
209 (29.6)
[26.2–32.9]
Total 5,349 1,601 (29.9)
[28.7–31.2]
1,150 (21.5)
[20.4–22.6]
1,202 (22.5)
[21.4–23.6]
1,396 (26.1)
[24.9–27.3]
Women
18–25 507 145 (28.6)
[24.7–32.5]
119 (23.5)
[19.8–27.2]
102 (20.1)
[16.6–23.6]
141 (27.8)
[23.9–31.7]
26–35 685 229 (33.4)
[29.9–37]
158 (23.1)
[19.9–26.2]
134 (19.6)
[16.6–22.5]
164 (23.9)
[20.8–27.4]
36–45 904 353 (39)
[35.9–42.2]
192 (21.2)
[18.6–23.9]
189 (20.9) 170 (18.8)
[18.3–23.6] [16.3–21.4]
46–55 747 274 (36.7)
[33.2–40.1]
144 (19.3)
[16.5–22.1]
156 (20.9)
[18–23.8]
173 (23.2)
[20.1–26.2]
56–66 453 134 (29.6)
[24.4–33.8]
84 (18.5)
[15–22.1]
116 (25.6)
[21.6–29.6]
119 (26.3)
[22.2–30.3]
Total 3,296 1,135 (34.4)
[32.8–36.1]
697 (21.1)
[19.8–22.5]
697 (21.1)
[19.8–22.5]
767 (23.3)
[21.8–24.7]
Men
18–25 347 76 (21.9)
[17.6–26.3]
75 (21.6)
[17.3–25.9]
75 (21.6)
[17.3–25.9]
121 (34.9)
[29.9–39.9]
26–35 431 99 (23)
[19–26.9]
104 (24.1)
[20.1–28.2]
84 (19.5)
[15.8–23.2]
144 (33.4)
[29–37.9]
36–45 578 145 (25.1)
[21.6–28.6]
126 (21.8)
[18.4–25.2]
155 (26.8)
[23.2–30.4]
152 (26.3)
[22.7–29.9]
46–55 443 93 (21)
[17.2–24.8]
105 (23.7)
[19.7–27.7]
123 (27.8)
[23.6–31.9]
122 (27.5)
[23.4–31.7]
56–66 254 53 (20.9)
[15.9–25.9]
43 (16.9)
[12.3–21.5]
68 (26.8)
[21.3–32.2]
90 (35.4)
[29.6–41.3]
Total 2,053 466 (22.7)
[20.9–24.5]
453 (22.1)
[20.3–23.9]
505 (24.6)
[22.7–26.5]
629 (30.6)
[28.6–32.6]
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123chronic MIG was found to be 2.4% and chronic TTH 2.2%.
In a large population-based survey from France, the overall
prevalence of chronic headache in subjects aged over
15 years was 2.9% out of which two-thirds had chronic
migraine [20]. In the USA, the overall prevalence of
chronic headache between 18 and 65 years was 4.1%
(female to male ratio: 1.8:1). Interestingly, the subjects in
this study more often reported chronic TTH ([50%) than
chronic MIG (female: 33%, male 25%) [21]. Chronic
headache that could not be clearly identiﬁed was found in
15% in women and 19% in men [21]. Subjects that reported
headache on 15 days/month or more in our study, chronic
MIG was more frequent (42.4, 47.6% in women and 32.6%
in men) than chronic TTH (19.6, 14.5% in women and
29.2% in men). The women to men ratio was 2.7:1 for
chronic MIG and 0.9:1 for chronic TTH.
The strengths of our study are the large population-based
sample recruited in 3 different regions of Germany, the high
Table 3 Chronic headache
CI conﬁdence interval, CH
chronic headache, cMIG chronic
migraine, cTTH chronic tension-
type headache, cUnclassiﬁable
chronic unclassiﬁable
CH age
groups
N cMIG n (%)
[95% CI]
cMIG ? TTH n (%)
[95% CI]
cTTH n (%)
[95% CI]
cUnclassiﬁable n (%)
[95% CI]
All
18–25 36 13 (36.1)
[20.4–51.8]
13 (36.1)
[20.4–51.8]
5 (13.9)
[2.6–25.2]
5 (13.9)
[2.6–25.2]
26–35 27 12 (44.4)
[25.7–63.2]
9 (33.3)
[15.6–51.1]
4 (14.8)
[1.4–28.2]
2 (7.4)
[0–17.3]
36–45 44 19 (43.2)
[28.6–57.8]
13 (29.5)
[16.1–43]
8 (18.2)
[6.8–29.6]
4 (9.1)
[0.6–17.6]
46–55 68 35 (51.5)
[39.6–63.4]
29 (42.6)
[30.9–54.4]
10 (14.7)
[6.3–23.1]
3 (4.4)
[0–9.3]
56–66 80 29 (36.3)
[25.7–46.8]
19 (23.7)
[14.4–33.1]
23 (28.8)
[18.8–38.7]
9 (11.3)
[4.3–18.2]
Total 255 108 (42.4)
[36.3–48.4]
74 (29)
[23.5–34.6]
50 (19.6)
[14.7–24.5]
23 (9)
[5.5–12.5]
Women
18–25 30 12 (40)
[22.5–57.5]
10 (33.3)
[16.5–50.2]
4 (13.3)
[1.2–25.5]
4 (13.3)
[1.2–25.5]
26–35 20 8 (40)
[18.5–61.5]
8 (40)
[18.5–61.5]
3 (15)
[0–30.7]
1 (5)
[0–14.6]
36–45 26 14 (53.8)
[34.7–73]
8 (30.8)
[13–48.5]
3 (11.5)
[0–23.8]
1 (3.8)
[0–11.2]
46–55 46 28 (60.9)
[46.8–75]
16 (34.8)
[21–48.6]
1 (2.2)
[0–6.4]
1 (2.2)
[0–6.4]
56–66 44 17 (38.6)
[24.3–53]
11 (25)
[12.2–37.8]
13 (29.5)
[16.1–43]
3 (6.8)
[0–14.3]
Total 166 79 (47.6)
[40–55.2]
53 (31.9)
[24.8–39]
24 (14.5)
[9.1–19.8]
10 (6)
[2.4–9.6]
Men
18–25 6 1 (16.7)
[0–46.5]
3 (50)
[10–90]
1 (16.7)
[0–46.5]
1 (16.7)
[0–46.5]
26–35 7 4 (57.1)
[20.5–93.8]
1 (14.3)
[0–40.2]
1 (14.3)
[0–40.2]
1 (14.3)
[0–40.2]
36–45 18 5 (27.8)
[7.1–48.5]
5 (27.8)
[7.1–48.5]
5 (27.8)
[7.1–48.5]
3 (16.7)
[0–33.9]
46–55 22 7 (31.8)
[12.4–51.3]
4 (18.2)
[2.1–34.3]
9 (40.9)
[20.4–61.5]
2 (9.1)
[0–21.1]
56–66 36 12 (33.3)
[17.9–48.7]
8 (22.2)
[8.6–35.8]
10 (27.8)
[13.2–42.4]
6 (16.7)
[4.5–28.8]
Total 89 29 (32.6)
[22.9–42.3]
21 (23.6)
[14.8–32.4]
26 (29.2)
[19.8–38.7]
13 (14.6)
[7.3–21.9]
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123response rate of 55%, and the use of a validated question-
naire. A false negative rate around 15% is compatible with
the sensitivities of our questionnaire for MIG (0.73) and
TTH (0.85) [4, 9].
Some limitations of our study need to be addressed.
Although the response of our survey was satisfactory,
possible selection bias might have occurred. For example,
very old and very young people more often refuse to take
part in surveys, and persons that suffer from headache
possibly more often participate in survey seemingly
affecting them, than persons not suffering from headache at
all. However, these limitations pose a challenge that all
questionnaire-based surveys have to face.
In conclusion, we provided comprehensive and detailed
prevalence estimates of primary headache disorders in the
general population in Germany. These data are valuable in
emphasizing the importance of episodic and chronic
headache in regard to health economics and the burden of
disease within a population. The next steps will have to
include the in-depth investigation of associated risk factors
that may be associated with episodic headache and lead to
chronic headache. There is much more to learn about the
role of possible inﬂuencing factors like socioeconomic
status, smoking, or obesity on headache prevalence in the
general population.
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